ATP1A3 SYMPOSIUM IN DISEASE – REYKJAVIK 2019
Karin Lykke-Hartmann
talks to AHC International Media about her involvement with ATP1A3 and gene therapy. Karin explains the newest development in the research on ATP1A3 and how the different methods work or how they should work in theory.
Karin Lykke-Hartmann works at the Department of Biomedicine and Clinical Medicine, Aarhus University, and the Clinical genetics, at Aarhus University Hospital, Denmark. Karin does research in Neuroscience, Developmental Biology and Cell Biology.
